Advertisement

Topics

Companies Related to "Global Cervical Cancer Partnering 2010 2017 Updated 01022017" [Most Relevant Company Matches] RSS

01:31 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "Global Cervical Cancer Partnering 2010 2017 Updated 01022017" found in our extensive corporate database of over 50,000 company records.

Showing "Global Cervical Cancer Partnering 2010 2017 Updated 01022017" Companies 1–25 of 7,200+

Extremely Relevant

Cervical Cancer-Free America

Cervical cancer is caused by persistent infections with high-risk types of the human papillomavirus (HPV). HPV is a very common sexually transmitted infection that 3 of 4 adults will have at some time in their lives. HPV vaccines are now available and target the two types of HPV that are responsible for 70 percent of all cervical cancers and are FDA-approved for girls and young women up to age 26....


Relevant

Digene

A leader in molecular diagnostics, Digene develops, manufactures and markets proprietary DNA and RNA tests focused on women's cancers and infectious diseases. The company's flagship product, The Digene® HPV Test* (DNAwithPap® Test), is the only FDA–approved test for the human papillomavirus (HPV), the primary cause of cervical cancer. Rapidly emerging as a standard of practice in cervical canc...

Mtm laboratories AG

mtm laboratories is a certified developer and manufacturer of In-vitro Diagnostics for screening and diagnosis of cervical cancer with products marketed world-wide. The privately held company is headquartered in Heidelberg, Germany, with a subsidiary in Westborough (MA), USA.mtm’s products target the largest existing screening market in oncology. The biomarker-based diagnostic assays promis...


GeneMax

GeneMax develops innovative immunotherapies in the fields of oncology and infectious disease. Our patented technology restores or increases antigen processing and antigen specific immune responses. GeneMax has demonstrated preclinical efficacy in animal models of lung cancer and melanoma as well as proof of principle for infectious disease pathogens.GeneMax’s program also includes developing a t...

Genomic Health, Inc.

Genomic Health, Inc. (NASDAQ: GHDX) is a life science company focused on the global development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched the Oncotype DX® breast cancer test, which has been shown to predict the likelihood of chemotherapy benefit as w...

IncellDx, Inc.

IncellDx, Inc. is a molecular diagnostics company dedicated to revolutionizing healthcare one cell at a time. By combining molecular diagnostics with high throughput cellular analysis, we focus on critical life threatening diseases such as HIV/AIDS, HPV/Cervical Cancer, Hepatitis, organ transplant infections, breast cancer and ovarian cancer.

Providence Medical Technology, Inc.

Providence Medical Technology is a privately held medical device company developing minimally invasive solutions addressing the $1 billion worldwide cervical fusion market. The company is commercializing the DTRAX platform of cervical devices, which are used to provide indirect decompression and fusion in patients suffering from cervical radiculopat...

mtm laboratories

mtm laboratories AG is an ISO 9001 and ISO 13485 certified developer and manufacturer of In-Vitro Diagnostic Devices (IVDD) for use in the early detection and diagnosis of cervical cancer. The Company operates on a global basis with headquarters in Heidelberg, Germany and subsidiaries in the United States, France, Italy and Spain. Further information can b...

Cytyc

Cytyc Corporation, based in Boxborough, Massachusetts (USA), designs, develops, manufactures, and markets sample preparation systems for medical diagnostics. Founded in 1987, Cytyc has dedicated its scientific expertise and resources to developing the ThinPrep® System to address the limitations of the 50-year-old conventional Pap smear. At the center of the ThinPrep System is the ThinPrep® Pap T...

Guided Therapeutics, Inc.

Guided Therapeutics, Inc. (OTCBB: GTHP) is developing a rapid and painless test for the early detection of disease that leads to cervical cancer. The technology is designed to provide an objective result at the point of care thereby improving the management of cervical disease. Unlike Pap and HPV tests, the device does not require a painful tissue sample a...

Biomoda, Inc.

Biomoda (www.biomoda.com) is a cancer diagnostics company focused on the development of accurate, inexpensive and noninvasive tests for the early detection of cancer. In addition to its first product for lung cancer, diagnostic assays for cervical, breast, colorectal, bladder, and oral cancers are targeted for development. Current research and development ...

Prostate Oncology Specialists, Inc.

According to the American Cancer Society, prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than two million men in the United States have prostate cancer, with an estimated 217,730 new cases and approximately 32,050 men expected to die from the disease in 2010.

EvaluatePharm

EvaluatePharma® – helping you to analyse the past and future performance of the pharmaceutical and biotechnology business sector.EvaluatePharma® provides comprehensive coverage of more than 400 companies and over 11,000 products from early stage R&D through to Marketed and beyond, tracking the past and future performance of the pharma and biotech business sectors.Historic sales (since 1986), c...

Genexine Inc.

Genexine, Inc, listed on KOSDAQ (095700-KQ) since 2009, is a clinical stage biotherapeutics company focused on immuno-oncology,metabolic and autoimmune diseases. Genexine has robust R&D pipelines in clinical and pre-clinical stages based on long-acting Fc fusion technology and therapeutic DNA vaccine technology. In the clinical stage, Genexine has GX-H9 (l...

ITT Exelis

ITT Exelis is a diversified, top-tier global aerospace, defense and information solutions company with strong positions in enduring and emerging global markets. Exelis is a leader in networked communications, sensing and surveillance, electronic warfare, navigation, air traffic solutions and information systems with growing positions in cyber security, com...

CytoCore

CytoCore, Inc. is a publicly traded biotechnology company (BB:CYCR) that is developing a proteomic-based method of screening and diagnosis for endometrial and cervical cancer. The company's major product is called the InPath™ System and is comprised of four distinct components: the e Collector™, protein-based biochemical cocktails and Slide Based Tests, the AIPS™ microscope platform, and a d...

EBD Group, Inc.

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

OvaGene Oncology Inc.

OvaGene Oncology is a molecular diagnostics company, located in Orange County, California, dedicated to improving cancer care and outcomes for gynecologic cancer patients through the development of novel gene-based assays. The company plans to offer proprietary and non-proprietary molecular diagnostic assays to assist physicians in the prognosis of gynecologic cancers as well as therapy selection...

Providence Medical Technology

Providence Medical Technology is a private corporation focused on developing novel minimally invasive technologies. We are commercializing the DTRAX platform of posterior cervical devices, which are used to provide indirect decompression and fusion in patients suffering from cervical degenerative disease.

EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

ACT Biotech Inc.

ACT Biotech (www.actbiotech.com) is a San Francisco-based, privately-held biopharmaceutical company focused on the development and commercialization of targeted cancer drugs. The Company's clinical stage pipeline also includes Telatinib, the most selective oral VEGF/PDGFR/KIT inhibitor ever developed. Telatinib is currently being studied in a Phase 2 trial...

MD Anderson Proton Therapy

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 40 comprehensive cancer centers designated by the National Cancer Institute. For seven of the past nine years, including 2010, MD Anderson has ranked No. 1 in cancer care in "America's Best Hos...

Cancer Prevention Coalition

On April 22, 2010, Senators Dianne Feinstein and Sam Brownback urged the Senate to pass the 2009 Lung Cancer Mortality Reduction Act. This stated that "lung cancer is the leading cause of cancer death in both men and women, accounting for 28 percent of all cancer deaths." The Act also warned that "two-thirds of nonsmokers diagnosed with lung cancer are wom...

DIAMICS, INC

Diamics mission is to work in partnership with both individual and institutional experts to develop and market cost-effective molecular-based cancer screening and diagnostic systems that will increase long-term survival rates through early detection. Cancers that can be detected earlier by screening account for at least half of all new cancer cases.1 In addition to cervical cancer, these cancers ...

Pharmalicensing.com

Pharmalicensing is the number one partnering resource for the biopharmaceutical industry, providing essential online support for executives involved with partnering, licensing and business development.Find out more about our global audience. Effective - straight to the world's leading healthcare corporations Global - from large pharmaceutical companies to niche therapeutic specialists Active promo...


More From BioPortfolio on "Global Cervical Cancer Partnering 2010 2017 Updated 01022017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks